You may need to avoid some type 2 diabetes medications if you have certain conditions. For example, thiazolidinediones (Actos) aren’t recommended for people with liver problems or a history of ...

Background and Aims: Neuropathy in association with chronic liver disease, including cirrhosis, is recognized; however, there are differences in the incidence and type of neuropathy reported.

Biomarkers in Blood to Predict Liver Cancer May 1, 2024 — Early detection has the potential to transform treatment and outcomes ... which are linked to liver cirrhosis and other serious health ...

She had cirrhosis, severe scarring ... and many doctors are hopeful that weight-loss drugs like Ozempic could also help stop the progression of liver disease. The Food and Drug Administration ...

Thirty-three patients with liver cirrhosis were investigated clinically and electrophysiologically. Nerve-conduction abnormalities were present in 24 (73%) patients compared with 71% reported in a ...

Dr. Steven-Huy Han, a UCLA liver specialist, has prescribed Ocaliva to a handful of patients, although he’s not sure it helps ...

Consuming 2 to 3 cups of green tea daily may facilitate fat metabolism and diminish inflammation within the liver, thereby assisting in the treatment of fatty liver disease. Cinnamon helps ...

Hypothyroidism, for example, might lead to NASH, cirrhosis ... of nonalcoholic liver disease Specific endocrine disorders might promote metabolic liver disease and, given that treatment is ...

Primary liver cancer ... usually need treatment. This can depend on the size of the tumour and whether it's causing symptoms. Journal of Hepatology, 2016. Volume 65, Issue 2, pages 386-398 The ...

New research from the University of Pittsburgh School of Pharmacy sheds light on the processes that lead to liver fibrosis and suggests a novel treatment ... and may lead to cirrhosis or even ...

The liver biopsy market is expanding as it remains essential for diagnosing liver diseases despite the rise of non-invasive alternatives. Advances in technology and increasing liver disease prevalence ...

The U.S. FDA Breakthrough Therapy designation is for the treatment of adults with non-cirrhotic metabolic dysfunction-associated steatohepatitis ...